NCT02392702View on ClinicalTrials.gov

Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

C-10355

DRUG

C-10358

DRUG

Kalydeco

Trial Locations (1)

5000

CMAX, Adelaide

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY